Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.31% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EFOR
2676
Everforth Inc
EFOR
$1.34B
| $669K | ﹤0.01% |
+13,794
| New | +$639K |
|
2677
Trip.com Group
TCOM
$28.7B
| $669K | ﹤0.01% |
+13,612
| New | +$624K |
|
2678
Cineverse
CNVS
$68.9M
| $668K | ﹤0.01% |
21,552
+5,655
| +36% | +$157K |
|
2679
Oil States International
OIS
$536M
| $663K | ﹤0.01% |
20,000
-75,300
| -79% | -$2.76M |
|
2680
Ralph Lauren
RL
$23.6B
| $661K | ﹤0.01% |
8,100
-57,200
| -88% | -$4.72M |
|
|
PVLA
2681
Palvella Therapeutics
PVLA
$2.23B
| $661K | ﹤0.01% |
+3,180
| New | +$563K |
|
2682
Turning Point Brands
TPB
$1.73B
| $658K | ﹤0.01% |
+42,200
| New | +$572K |
|
|
HWCC
2683
DELISTED
Houston Wire & Cable Company
HWCC
| $657K | ﹤0.01% |
97,400
+2,200
| +2% | +$15.1K |
|
|
ENFY
2684
DELISTED
Enlightify Inc
ENFY
| $656K | ﹤0.01% |
42,038
-2,012
| -5% | -$31.5K |
|
2685
Coffee Holding Co
JVA
$20.2M
| $651K | ﹤0.01% |
140,100
-20,700
| -13% | -$96.5K |
|
2686
DLH Holdings
DLHC
$67.8M
| $649K | ﹤0.01% |
120,140
+13,250
| +12% | +$75.1K |
|
|
EVBS
2687
DELISTED
Eastern Virginia Bankshares In
EVBS
| $649K | ﹤0.01% |
61,900
-2,429
| -4% | -$25.4K |
|
2688
DHT Holdings
DHT
$3.01B
| $645K | ﹤0.01% |
+144,300
| New | +$669K |
|
2689
First Bank
FRBA
$469M
| $641K | ﹤0.01% |
53,600
+39,300
| +275% | +$496K |
|
|
CWAY
2690
DELISTED
Coastway Bancorp, Inc.
CWAY
| $641K | ﹤0.01% |
36,400
+9,300
| +34% | +$157K |
|
|
CSCI
2691
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
| $640K | ﹤0.01% |
2,134
-946
| -31% | -$278K |
|
|
TGH
2692
DELISTED
Textainer Group Holdings limited
TGH
| $640K | ﹤0.01% |
41,800
-178,300
| -81% | -$2.43M |
|
|
MLVF
2693
DELISTED
Malvern Bancorp, Inc.
MLVF
| $640K | ﹤0.01% |
30,400
-4,400
| -13% | -$91.8K |
|
|
INFN
2694
DELISTED
Infinera Corporation Common Stock
INFN
| $635K | ﹤0.01% |
62,100
-328,173
| -84% | -$3.29M |
|
|
VSR
2695
DELISTED
Versar, Inc.
VSR
| $635K | ﹤0.01% |
380,500
+15,500
| +4% | +$19.7K |
|
|
NEWR
2696
DELISTED
New Relic, Inc.
NEWR
| $634K | ﹤0.01% |
17,100
-63,262
| -79% | -$2.22M |
|
|
ENFC
2697
DELISTED
Entegra Financial Corp.
ENFC
| $634K | ﹤0.01% |
26,800
-10,778
| -29% | -$242K |
|
|
GTLS
2698
DELISTED
Chart Industries
GTLS
| $632K | ﹤0.01% |
18,100
+7,500
| +71% | +$278K |
|
|
CGRN
2699
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
| $632K | ﹤0.01% |
82,551
+6,840
| +9% | +$51.4K |
|
|
BORN
2700
DELISTED
China New Borun Corporation
BORN
| $629K | ﹤0.01% |
537,300
-20,200
| -4% | -$25.1K |
|
Similar funds
Jim Simons's Q1 2017 Portfolio in Review
As of Q1 2017, Jim Simons held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Jim Simons's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Jim Simons added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Jim Simons's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Jim Simons fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Jim Simons's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Jim Simons opened 433 new positions and closed 462 in Q1 2017.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.